4E1-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma[J]. Gastroen- terology, 2004, 126(2) : 460-468.
5Hemminkiac K, Li X, Sundquistc J, et al. Risk of cancer fol- lowing hospitallization for type 2 diabetes [ J ] Oncologist, 2010, 15(6) : 548-555.
6Sun L, Yu S. Diabetes rnellitns is an independent risk factor for colorectal eaneer[J]. Dig Dis Sci, 2012, 57(6) : 1586-1597.
7Hall GC, Roberts CM, Boulis M, et al. Diabetes and the risk of lung cancer[J]. Diabetes Care, 2005, 28: 590-594.
8Currie CJ, Poole CD, Jenkins-Jones S, et al. Mortality after inci- dent cancer in people with and without type 2 diabetes : impact of mefformin on survival [ J ]. Diabetes Care, 2012, 35 ( 2 ) : 299- 304.
9Mazzone PJ, Rai H, Beukemann M, et al. The effect of metform- in and thiazoli-dinedone use on lung cancer in diabetics [ J ]. BMC Cancer, 2012, 12(410) : 1-7.
10Tan BX, Yao WX, Ge J, et al. Prognostic influence of metform- in as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes [ J]. Cancer, 2011, 117 (22) : 5103-5111.
